Premium
Meta‐analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium‐glucose co‐transporter‐2 inhibitors: Implications for the COVID‐19 pandemic
Author(s) -
Patoulias Dimitrios,
Papadopoulos Christodoulos,
Boulmpou Aristi,
Doumas Michael
Publication year - 2021
Publication title -
diabetes, obesity and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.445
H-Index - 128
eISSN - 1463-1326
pISSN - 1462-8902
DOI - 10.1111/dom.14359
Subject(s) - medicine , placebo , pandemic , confidence interval , relative risk , meta analysis , canagliflozin , upper respiratory tract infection , covid-19 , disease , infectious disease (medical specialty) , diabetes mellitus , endocrinology , pathology , type 2 diabetes , alternative medicine